Spatial Concept – Page 11

Dr. Mehmet Oz Nominated to Lead Centers for Medicare and Medicaid Services

1 year ago talkbio0Tagged Dr., healthcare leadership, Medicaid, Medicaid Services, Medicare, nomination, ounce, Transplant Registry Unified Management Program

Dr. Mehmet Oz, Medicare, Medicaid, Centers for Medicare and Medicaid Services, Trump nomination, healthcare leadership

Merck’s Subcutaneous Keytruda Shows Non-Inferiority in Phase 3 Trial, Paving Way for Regulatory Discussions

1 year ago talkbio0Tagged Immunotherapy for cancer, Keytruda, Merck, non-inferiority, Phase 3 trial, regulatory, subcutaneous, submissions

Merck, Keytruda, subcutaneous, cancer immunotherapy, phase 3 trial, non-inferiority, regulatory submissions

Daiichi Sankyo and Alteogen Collaborate on Subcutaneous Enhertu Development in $300M Licensing Agreement

1 year ago talkbio0Tagged Alteogen, Cancer Therapeutic Procedure, Daiichi, Enhertu, Homo sapiens, hyaluronidase, Sankyo, subcutaneous

Daiichi Sankyo, Alteogen, subcutaneous Enhertu, $300M licensing deal, human hyaluronidase, cancer treatment

Sarepta Therapeutics Halts Development of Vesleteplirsen, a Next-Generation Exon-Skipping Therapy for Duchenne Muscular Dystrophy

1 year ago talkbio0Tagged Duchenne, Exon-Skipping Therapy, Feedback - system communication, Landscapes, Muscular Dystrophy, Muscular Dystrophy, Duchenne, SRP-5051, United States Food and Drug Administration, Vesleteplirsen

Sarepta Therapeutics, Vesleteplirsen (SRP-5051), Duchenne Muscular Dystrophy (DMD), Exon-Skipping Therapy, FDA Feedback, Therapeutic Landscape

CMS Approves Transitional Pass-Through Payments for Renal Denervation Systems from Medtronic and Recor Medical

1 year ago talkbio0Tagged Hypertensive disease, Medtronic, Myasthenic Syndromes, Congenital, Payments, Recor Medical, Renal Denervation Systems, Transitional cell morphology

Renal Denervation Systems, CMS, Transitional Pass-Through Payments, Medtronic, Recor Medical, Hypertension Treatment

HIV Prevention: A Proven Solution Eludes Many Due to Systemic Barriers

1 year ago talkbio0Tagged Access, Community, Health care facility, Health Equity, HIV Prevention, marginalized, Pre-Exposure Prophylaxis, PREP gene, Social stigmata

HIV Prevention, PrEP (Pre-Exposure Prophylaxis), Health Equity, Marginalized Communities, Stigma, Access to Healthcare

Pfizer Withdraws Sickle Cell Disease Treatment Oxbryta Globally Due to Safety Concerns

1 year ago talkbio0Tagged Anemia, Sickle Cell, Clinical Trials, concerns, Event, Fatal, Generalized, Market, Oxbryta, Pfizer, Safety, vaso-occlusive crises, Withdraw (activity)

Pfizer, Oxbryta, sickle cell disease, global market withdrawal, safety concerns, clinical trials, vaso-occlusive crises, fatal events

Telix Acquires RLS to Bolster Radiopharmaceutical Manufacturing and Distribution in North America

1 year ago talkbio0Tagged Acquisition (action), North America, production, radiometal, Radiopharmaceuticals, Restless Legs Syndrome, Social Networks, Spatial Distribution, Telix

Telix Pharmaceuticals, RLS (USA) Inc., radiopharmaceutical manufacturing, distribution, acquisition, North America, radiometal production network

Upstream Biotech Prepares to Join the Wave of Biotech IPOs with Inflammation-Focused Therapies

1 year ago talkbio0Tagged biotech, Biotechnology, healthcare innovation, Industry, Inflammation-Focused Therapies, IPOs, offerings, public entity, Upstream

Biotech IPOs, Upstream Biotech, Inflammation-focused therapies, Biotechnology industry, Public offerings, Healthcare innovation

KEYTRUDA (Pembrolizumab) Plus Chemoradiotherapy Reduces Mortality Risk by 33% in High-Risk Locally Advanced Cervical Cancer

1 year ago talkbio0Tagged Chemoradiotherapy, Congress, Congress (U.S. Legislature), high-risk, Keytruda, Locally, Malignant tumor of cervix, Overall Survival, pembrolizumab

KEYTRUDA (pembrolizumab), Chemoradiotherapy (CRT), High-risk locally advanced cervical cancer, Overall survival (OS), European Society for Medical Oncology (ESMO) Congress 2024